Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Tanaka, Motoyuki ^a   Setoguchi, Takao ^a   Ishidou, Yasuhiro ^a   Arishima, Yoshiya ^a   Hirotsu, Masataka ^a   Saitoh, Yoshinobu ^a   Nakamura, Shunsuke ^a   Kakoi, Hironori ^a   Nagano, Satoshi ^a   Yokouchi, Masahiro ^a   Kamizono, Junichi ^a   Komiya, Setsuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adefovir dipivoxil; Fanconi's syndrome; Hepatitis B; Osteomalacia; Pathological femoral neck fracture

Indexed keywords

ADEFOVIR DIPIVOXIL; ADENINE; ANTIVIRUS AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FANCONI RENOTUBULAR SYNDROME; FEMUR NECK FRACTURE; HEPATITIS B; HIP ARTHROPLASTY; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMALACIA; PREDICTIVE VALUE; RADIOGRAPHY; TREATMENT OUTCOME; WHOLE BODY IMAGING;

ADENINE; ANTIVIRAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; FANCONI SYNDROME; FEMORAL NECK FRACTURES; HEPATITIS B, CHRONIC; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOPHOSPHONATES; OSTEOMALACIA; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TREATMENT OUTCOME; WHOLE BODY IMAGING;

EID: 84868518297     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-108     Document Type: Article

References (28)

1. Clarke BL, Wynne AG, Wilson DM, Fitzpatrick LA. Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin Endocrinol 1995, 43:479-490.
2. Verhelst D, Monge M, Meynard JL, Fouqueray B, Mougenot B, Girard PM, Ronco P, Rossert J. Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am J Kidney Dis 2002, 40:1331-1333. 10.1053/ajkd.2002.36924, 12460055.
3. Earle KE, Seneviratne T, Shaker J, Shoback D. Fanconi's syndrome in HIV + adults: report of three cases and literature review. J Bone Miner Res 2004, 19:714-721. 10.1359/jbmr.2004.19.5.714, 15068493.
4. Parsonage MJ, Wilkins EG, Snowden N, Issa BG, Savage MW. The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. HIV Med 2005, 6:341-346. 10.1111/j.1468-1293.2005.00318.x, 16156882.
5. Zimmermann AE, Pizzoferrato T, Bedford J, Morris A, Hoffman R, Braden G. Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2006, 42:283-290.
6. Malik A, Abraham P, Malik N. Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment-case report and review of literature. J Infect 2005, 51:E61-E65. 10.1016/j.jinf.2004.08.031, 16038754.
7. Garden RS. LOW-ANGLE FIXATION IN FRACTURES OF THE FEMORAL NECK. J Bone Joint Surg Br 1961, 43-B:647-663.
8. Ott SM. Bone histomorphometry in renal osteodystrophy. Semin Nephrol 2009, 29:122-132. 10.1016/j.semnephrol.2009.01.005, 19371803.
9. Wong T, Girgis CM, Ngu MC, Chen RC, Emmett L, Archer KA, Seibel MJ. Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B. J Clin Endocrinol Metab 2010, 95:479-480. 10.1210/jc.2009-2051, 20133467.
10. Kahn J, Lagakos S, Wulfsohn M, Cherng D, Miller M, Cherrington J, Hardy D, Beall G, Cooper R, Murphy R, et al. Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. Jama 1999, 282:2305-2312. 10.1001/jama.282.24.2305, 10612317.
11. Izzedine H, Kheder-Elfekih R, Housset P, Sarkozy C, Brocheriou I, Deray G. Adefovir dipivoxil-induced acute tubular necrosis and Fanconi syndrome in a renal transplant patient. AIDS (London, England) 2009, 23:544-545.
12. Jung YK, Yeon JE, Choi JH, Kim CH, Jung ES, Kim JH, Park JJ, Kim JS, Bak YT, Byun KS. Fanconi's syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis B virus patient. Gut and Liver 2010, 4:389-393. 10.5009/gnl.2010.4.3.389, 2956354, 20981219.
13. Minemura M, Tokimitsu Y, Tajiri K, Nakayama Y, Kawai K, Kudo H, Hirano K, Atarashi Y, Yata Y, Yasumura S, et al. Development of osteomalacia in a post-liver transplant patient receiving adefovir dipivoxil. World J Hepatol 2010, 2:442-446. 10.4254/wjh.v2.i12.442, 3010514, 21191520.
14. Lee HJ, Choi JW, Kim TN, Eun JR. A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus. The Korean Journal of Hepatology 2008, 14:381-386. 10.3350/kjhep.2008.14.3.381, 18815461.
15. Tanji N, Tanji K, Kambham N, Markowitz GS, Bell A, D'Agati VD. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol 2001, 32:734-740. 10.1053/hupa.2001.25586, 11486172.
16. Cihlar T, Lin DC, Pritchard JB, Fuller MD, Mendel DB, Sweet DH. The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol Pharmacol 1999, 56:570-580.
17. Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G. Drug-induced Fanconi's syndrome. Am J Kidney Dis 2003, 41:292-309. 10.1053/ajkd.2003.50037, 12552490.
18. Asselah T, Lada O, Boyer N, Martinot M, Marcellin P. Treatment of chronic hepatitis B. Gastroenterol Clin Biol 2008, 32:749-768. 10.1016/j.gcb.2008.07.001, 18775613.
19. Lai CL, Rosmawati M, Lao J, Van Vlierberghe H, Anderson FH, Thomas N, Dehertogh D. Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. Gastroenterology 2002, 123:1831-1838. 10.1053/gast.2002.37058, 12454840.
20. Chang TT, Gish RG, Hadziyannis SJ, Cianciara J, Rizzetto M, Schiff ER, Pastore G, Bacon BR, Poynard T, Joshi S, et al. A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients. Gastroenterology 2005, 129:1198-1209. 10.1053/j.gastro.2005.06.055, 16230074.
21. Melnick JZ, Baum M, Thompson JR. Aminoglycoside-induced Fanconi's syndrome. Am J Kidney Dis 1994, 23:118-122.
22. Yoshikawa H, Watanabe T, Abe T. Fanconi syndrome caused by sodium valproate: report of three severely disabled children. Eur J Paediatr Neurol 2002, 6:165-167. 10.1053/ejpn.2002.0585, 12363104.
23. Otten J, Vis HL. Acute reversible renal tubular dysfunction following intoxication with methyl-3-chromone. J Pediatr 1968, 73:422-425. 10.1016/S0022-3476(68)80124-6, 5667427.
24. Vaziri ND, Ness RL, Fairshter RD, Smith WR, Rosen SM. Nephrotoxicity of paraquat in man. Arch Intern Med 1979, 139:172-174. 10.1001/archinte.1979.03630390032014, 434971.
25. Lo JC, Chertow GM, Rennke H, Seifter JL. Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion. Am J Kidney Dis 1996, 28:614-617. 10.1016/S0272-6386(96)90476-X, 8840955.
26. Varavithya W, Chulajata R, Ayudthya PS, Preeyasombat C. Fanconi syndrome caused by degraded tetracycline. J Med Assoc Thail= Chotmaihet thangphaet 1971, 54:62-67.
27. Negro A, Regolisti G, Perazzoli F, Davoli S, Sani C, Rossi E. Ifosfamide-induced renal Fanconi syndrome with associated nephrogenic diabetes insipidus in an adult patient. Nephrol Dial Transplant 1998, 13:1547-1549. 10.1093/ndt/13.6.1547, 9641191.
28. Morard I, Mentha G, Spahr L, Majno P, Hadengue A, Huber O, Morel P, Giostra E. Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels. Clin Transplant 2006, 20:96-101. 10.1111/j.1399-0012.2005.00447.x, 16556162.